Melanoma cells are cultured with autologous TILs to identify known mechanisms of ICI resistance (Figure 1E), such as impaired IFNγ-JAK/STAT and antigen presentation pathways, as well as novel mechanisms such as CD58 downregulation. This evidence concerns the gene IFNG and melanoma.